Breeden Richard C sold $310K of STE
Breeden Richard C sold 1,481 shares of STERIS plc (STE) at $209.51 ($0.31M total) on 2026-06-02.
How this was made
The 30-second read
Why it matters
The disclosure updates insider activity records but does not introduce new company fundamentals (earnings, guidance, deals, litigation, or regulatory actions).
Market read
Primarily a sentiment/positioning datapoint for STE; likely limited trading impact absent additional catalysts.
What to watch
Insider sales often occur for non-informational reasons (taxes, planned diversification, personal liquidity), and the article provides no follow-on guidance or performance change.
Background
The article is an SEC Form 4 insider transaction disclosure for STERIS plc, reported by a director.
Ticker impact
STERIS director Richard C Breeden sold 1,481 shares in an open-market transaction at ~$209.51 on 2026-06-02, disclosed via Form 4.
Low likelihood of a sustained price move; any reaction is likely short-lived and sentiment-driven.
The filing reports a routine Form 4 sale with no 10b5-1 plan stated and no accompanying company-specific operational or financial news.
Market effects
Minimal; single-company insider transaction without sector-wide implications.
None indicated.
None indicated.
Counterpoint
Because the sale is open-market and the filing lacks a stated 10b5-1 plan, traders may overinterpret it; it could still be routine liquidity or diversification.
Key entities
- issuerSTERIS plc
Subject of the SEC Form 4 insider sale disclosure.
- insiderBreeden Richard C
Director who sold 1,481 shares on 2026-06-02.
